PacBio to Report Third Quarter 2024 Financial Results on November 7, 2024
Rhea-AI Summary
PacBio (NASDAQ: PACB) has announced its upcoming third quarter 2024 financial results conference call, scheduled for Thursday, November 7, 2024, at 4:30 pm Eastern Time (1:30 pm Pacific Time). Investors and interested parties can access the webcast through PacBio's investor relations website at https://investor.pacificbiosciences.com/.
For those preferring a dial-in option, the following numbers are provided:
- Toll-free: 1-888-349-0136
- International: 1-412-317-0459
Participants using the dial-in option are advised to join the call ten minutes before the start time and ask to join the 'PacBio Q3 Earnings Call'. A replay of the webcast will be available on the company's investor relations website after the call.
Positive
- None.
Negative
- None.
MENLO PARK, Calif., Oct. 10, 2024 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB) announced today that it will hold its quarterly conference call to discuss its third quarter 2024 financial results on Thursday, November 7, 2024, at 4:30 pm Eastern Time.
The call will be webcast and may be accessed at PacBio’s website at https://investor.pacificbiosciences.com/.
Date: Thursday, November 7, 2024, at 4:30 pm ET (1:30 pm PT)
Listen live via internet or replay: https://investor.pacificbiosciences.com/
Toll-free: 1-888-349-0136
International: 1-412-317-0459
If using the dial-in option, please join the call ten minutes before the start time using the appropriate number above and ask to join the “PacBio Q3 Earnings Call.”
About PacBio
Pacific Biosciences of California, Inc. (NASDAQ: PACB) is a premier life science technology company that designs, develops, and manufactures advanced sequencing solutions to help scientists and clinical researchers resolve genetically complex problems. Our products and technologies stem from two highly differentiated core technologies focused on accuracy, quality, and completeness, which include our HiFi long-read sequencing and our SBB® short-read sequencing technologies. Our products address solutions across a broad set of research applications, including human germline sequencing, plant and animal sciences, infectious disease and microbiology, oncology, and other emerging applications. For more information, please visit www.pacb.com and follow @PacBio.
PacBio products are provided for Research Use Only. Not for use in diagnostic procedures.
Contacts
Investors:
Todd Friedman
ir@pacb.com
Media:
pr@pacb.com
FAQ
When will PacBio (PACB) report its Q3 2024 financial results?
How can investors access PacBio's (PACB) Q3 2024 earnings call?
What time does PacBio's (PACB) Q3 2024 earnings call start in Pacific Time?
Will there be a replay available for PacBio's (PACB) Q3 2024 earnings call?
